Technical Resource Center

The Product Pillars

Full technical specifications for our three core bio-active platforms. All products produced under our BioSync™ 3rd-Gen Precision Yeast Synthesis technology. Manufactured for Morika Bio.

BioSync™ Platform

Human Milk Oligosaccharides

Our HMO portfolio represents the pinnacle of precision yeast synthesis. Using the BioSync™ platform, we achieve 99.9% purity while completely eliminating endotoxin risk associated with legacy E. coli-based production methods.

Endotoxin-Free & E. coli-Free

Our yeast-based BioSync™ process inherently eliminates endotoxin contamination, providing a critical safety advantage over bacterial fermentation systems.

Available Variants

2'-Fucosyllactose (2'-FL)Lacto-N-tetraose (LNT)Lacto-N-neotetraose (LNnT)3-Fucosyllactose (3-FL)Lacto-N-triose II (LNTr II)
BioSync fermentation

Technical Specifications

Purity (HPLC)

99.9%

pH (1% solution)

6.7 (Neutral)

Moisture

< 0.2%

Endotoxin Risk

Zero

Production Host

Yeast (E. coli-Free)

Regulatory

First FDA GRAS for LNTr II

Sustainable bio-fermentation

Technical Specifications

Purity (HPLC)

98%

Source

BioSync™ Yeast Synthesis

CITES Status

100% Compliant

Heavy Metals

Zero Contamination

Regulatory

ISO 9001, Halal

Format

Crystalline Powder

BioSync™ Synthesis

Bio-Fermented Salidroside

Our fermentation-derived salidroside eliminates the environmental and quality concerns of wild Rhodiola rosea harvesting. Through BioSync™ precision biosynthesis, we produce 98% pure salidroside that is free from heavy metals, pesticides, and the inconsistencies inherent in plant-extracted material.

100% CITES Compliance

Fully compliant with the Convention on International Trade in Endangered Species. Our fermentation process requires zero wild plant material.

Fermentation Advantages

  • 100% CITES-compliant -- no wild plant harvesting
  • Zero heavy metal contamination from soil uptake
  • Year-round consistent production
  • Scalable to metric ton quantities
  • Batch-to-batch consistency > 99%

37°N Signature Series

Marine Peptides

Sourced from 37°N premium ecological zones and processed through proprietary high-activity enzymatic hydrolysis, our marine peptides achieve standardized ultra-low molecular weights for rapid absorption in both nutritional and clinical skincare applications.

Standardized <1000 Da

Controlled enzymatic hydrolysis for maximum bioavailability and rapid transdermal penetration.

Thermal Stability

Maintains structural integrity across processing temperatures up to 180°C.

Premium Source

High-activity enzyme extraction from 37°N premium sea cucumber.

Marine environment

Technical Specifications

Molecular Weight

< 1000 Da (Standardized)

Source Zone

37°N Premium

Extraction

High-Activity Enzymatic

Grade

Clinical / Cosmetic

Regulatory

FDA GRAS, ISO 9001

Format

Hydrolyzed Powder